Epithelial-mesenchymal-transition regulators in prostate cancer: Androgens and beyond

Volume: 166, Pages: 84 - 90
Published: Feb 1, 2017
Abstract
Castration resistant prostate cancer (CRPC) remains one of the leading causes of cancer deaths among men. Conventional therapies targeting androgen signaling driven tumor growth have provided limited survival benefit in patients. Recent identification of the critical molecular and cellular events surrounding tumor progression, invasion, and metastasis to the bone as well as other sites provide new insights in targeting advanced disease....
Paper Details
Title
Epithelial-mesenchymal-transition regulators in prostate cancer: Androgens and beyond
Published Date
Feb 1, 2017
Volume
166
Pages
84 - 90
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.